Peel Hunt Reiterates Hold Rating for Victrex (LON:VCT)
Peel Hunt reiterated their hold rating on shares of Victrex (LON:VCT) in a research note published on Monday, ThisIsMoney.Co.Uk reports.
Other equities research analysts have also recently issued research reports about the company. Credit Suisse Group started coverage on Victrex in a research note on Monday, September 2nd. They issued an outperform rating and a GBX 2,700 ($35.28) target price on the stock. Liberum Capital restated a buy rating on shares of Victrex in a research note on Thursday, August 22nd. JPMorgan Chase & Co. cut their target price on Victrex from GBX 2,300 ($30.05) to GBX 2,150 ($28.09) and set a neutral rating on the stock in a research note on Friday, July 5th. Barclays upgraded Victrex to an equal weight rating and set a GBX 2,020 ($26.39) target price on the stock in a research note on Wednesday, August 21st. Finally, Stifel Nicolaus started coverage on Victrex in a research note on Monday, May 20th. They issued a buy rating and a GBX 2,255 ($29.47) target price on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. The stock has an average rating of Hold and an average target price of GBX 2,284.09 ($29.85).
LON:VCT opened at GBX 2,138 ($27.94) on Monday. Victrex has a fifty-two week low of GBX 1,813.68 ($23.70) and a fifty-two week high of GBX 3,434 ($44.87). The stock has a market capitalization of $1.84 billion and a PE ratio of 18.59. The business’s 50-day simple moving average is GBX 2,010.60 and its 200-day simple moving average is GBX 2,152.54.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
See Also: What is a support level?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.